Treatment with a commercially available 15-LOX-1 inhibitor, PD146176, markedly inhibited mouse MC38 tumor growth (123 ± 24 vs. 227 ± 40 mg/mouse of vehicle, P < 0.05, n = 10) (Figure 1A). The gene discussed is OLR1; the disease is neoplasm.